(VIANEWS) – Macquarie Global Infrastructure Total Return Fund (MGU), Eagle Point Credit Company (ECC), Brookfield Property Partners (BPYPP) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Macquarie Global Infrastructure Total Return Fund (MGU) | 18.08% | 2023-03-11 21:07:14 |
| Eagle Point Credit Company (ECC) | 14.65% | 2023-03-10 05:14:08 |
| Brookfield Property Partners (BPYPP) | 7.84% | 2023-03-20 14:39:10 |
| Paramount Group (PGRE) | 6.28% | 2023-03-12 15:15:09 |
| Radian Group (RDN) | 4.11% | 2023-03-12 21:14:08 |
| Novartis AG (NVS) | 4.02% | 2023-03-20 14:48:31 |
| Equity Residential (EQR) | 3.89% | 2023-03-20 14:54:47 |
| NextEra Energy (NEE) | 2.32% | 2023-03-20 14:57:21 |
| Royalty Pharma (RPRX) | 2.1% | 2023-03-20 14:59:29 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Macquarie Global Infrastructure Total Return Fund (MGU) – Dividend Yield: 18.08%
Macquarie Global Infrastructure Total Return Fund’s last close was $22.82, 14.82% below its 52-week high of $26.79. Intraday change was -1.21%.
Macquarie Global Infrastructure Total Return Fund Inc. is a closed-ended equity mutual fund launched and managed by Macquarie Fund Adviser, LLC. The fund invests in the public equity markets across the globe. It typically invests in companies operating in the infrastructure sector. Macquarie Global Infrastructure Total Return Fund Inc. was formed on August 26, 2005 and is domiciled in the United States.
Earnings Per Share
As for profitability, Macquarie Global Infrastructure Total Return Fund has a trailing twelve months EPS of $4.11.
PE Ratio
Macquarie Global Infrastructure Total Return Fund has a trailing twelve months price to earnings ratio of 5.55. Meaning, the purchaser of the share is investing $5.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.28%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.9%, now sitting on 15.51M for the twelve trailing months.
Volume
Today’s last reported volume for Macquarie Global Infrastructure Total Return Fund is 23198 which is 25.89% below its average volume of 31306.
More news about Macquarie Global Infrastructure Total Return Fund.
2. Eagle Point Credit Company (ECC) – Dividend Yield: 14.65%
Eagle Point Credit Company’s last close was $11.27, 18.8% below its 52-week high of $13.88. Intraday change was -1.74%.
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Eagle Point Credit Company has a trailing twelve months EPS of $-2.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.71%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 118.43M for the twelve trailing months.
Moving Average
Eagle Point Credit Company’s value is above its 50-day moving average of $10.80 and under its 200-day moving average of $11.27.
Yearly Top and Bottom Value
Eagle Point Credit Company’s stock is valued at $11.27 at 20:15 EST, way below its 52-week high of $13.88 and way above its 52-week low of $9.96.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 14.9% and 18.2%, respectively.
More news about Eagle Point Credit Company.
3. Brookfield Property Partners (BPYPP) – Dividend Yield: 7.84%
Brookfield Property Partners’s last close was $16.26, 30.39% under its 52-week high of $23.36. Intraday change was -1.17%.
Brookfield Property Partners, through Brookfield Property Partners L.P. and its subsidiary Brookfield Property REIT Inc., is one of the world's premier real estate companies, with approximately $88 billion in total assets. We own and operate iconic properties in the world's major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, self-storage, triple net lease, manufactured housing and student housing. Brookfield Property Partners is the flagship listed real estate company of Brookfield Asset Management Inc., a leading global alternative asset manager with over $540 billion in assets under management. More information is available at www.brookfield.com. As of July 26, 2021, Brookfield Property Partners L.P. operates as a subsidiary of Brookfield Asset Management Inc.
Earnings Per Share
As for profitability, Brookfield Property Partners has a trailing twelve months EPS of $-2.39.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.25%.
Volume
Today’s last reported volume for Brookfield Property Partners is 13433 which is 46.58% below its average volume of 25150.
Yearly Top and Bottom Value
Brookfield Property Partners’s stock is valued at $16.20 at 20:15 EST, way below its 52-week high of $23.36 and way above its 52-week low of $14.70.
More news about Brookfield Property Partners.
4. Paramount Group (PGRE) – Dividend Yield: 6.28%
Paramount Group’s last close was $4.82, 56.81% below its 52-week high of $11.16. Intraday change was -2.43%.
Headquartered in New York City, Paramount Group, Inc. is a fully-integrated real estate investment trust that owns, operates, manages, acquires and redevelops high-quality, Class A office properties located in select central business district submarkets of New York City and San Francisco. Paramount is focused on maximizing the value of its portfolio by leveraging the sought-after locations of its assets and its proven property management capabilities to attract and retain high-quality tenants.
Earnings Per Share
As for profitability, Paramount Group has a trailing twelve months EPS of $-0.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.64%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Paramount Group’s EBITDA is 6.14.
Volume
Today’s last reported volume for Paramount Group is 3449180 which is 145.67% above its average volume of 1403970.
More news about Paramount Group.
5. Radian Group (RDN) – Dividend Yield: 4.11%
Radian Group’s last close was $21.18, 11.42% under its 52-week high of $23.91. Intraday change was -3.29%.
Radian Group Inc., together with its subsidiaries, engages in the mortgage and real estate services business in the United States. The company operates in two segments, Mortgage Insurance and Services. The Mortgage Insurance segment offers credit-related insurance coverage, primarily through private mortgage insurance on residential first-lien mortgage loans, as well as other credit risk management solutions to mortgage lending institutions and mortgage credit investors. This segment primarily serves mortgage bankers, commercial banks, savings institutions, credit unions, and community banks. The Services segment offers mortgage services, including transaction management services, such as loan review, residential mortgage-backed securities securitization and distressed asset reviews, review and valuation services related to single family rental properties, servicer and loan surveillance, and underwriting; real estate services comprising real estate owned asset management, and real estate valuation and brokerage services, as well as software as a service solutions and platforms; and title services that include title insurance products, and closing services. This segment provides its mortgage and real estate services to mortgage lenders, financial institutions, investors, government entities, and others. The company was founded in 1977 and is headquartered in Philadelphia, Pennsylvania.
Earnings Per Share
As for profitability, Radian Group has a trailing twelve months EPS of $4.21.
PE Ratio
Radian Group has a trailing twelve months price to earnings ratio of 5.03. Meaning, the purchaser of the share is investing $5.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.17%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 23, 2023, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 4.11%.
More news about Radian Group.
6. Novartis AG (NVS) – Dividend Yield: 4.02%
Novartis AG’s last close was $82.19, 12.81% under its 52-week high of $94.26. Intraday change was 1.39%.
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Earnings Per Share
As for profitability, Novartis AG has a trailing twelve months EPS of $3.48.
PE Ratio
Novartis AG has a trailing twelve months price to earnings ratio of 23.95. Meaning, the purchaser of the share is investing $23.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
Volume
Today’s last reported volume for Novartis AG is 2335700 which is 14.57% above its average volume of 2038510.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 8, 2023, the estimated forward annual dividend rate is 3.47 and the estimated forward annual dividend yield is 4.02%.
Moving Average
Novartis AG’s value is under its 50-day moving average of $87.21 and under its 200-day moving average of $84.68.
More news about Novartis AG.
7. Equity Residential (EQR) – Dividend Yield: 3.89%
Equity Residential’s last close was $57.58, 38.95% below its 52-week high of $94.32. Intraday change was 0.89%.
Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.
Earnings Per Share
As for profitability, Equity Residential has a trailing twelve months EPS of $1.77.
PE Ratio
Equity Residential has a trailing twelve months price to earnings ratio of 32.76. Meaning, the purchaser of the share is investing $32.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.9%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 2.74B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 29, 2022, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 3.89%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Equity Residential’s stock is considered to be overbought (>=80).
Moving Average
Equity Residential’s worth is under its 50-day moving average of $62.34 and way under its 200-day moving average of $67.61.
More news about Equity Residential.
8. NextEra Energy (NEE) – Dividend Yield: 2.32%
NextEra Energy’s last close was $75.67, 17.16% below its 52-week high of $91.35. Intraday change was 0.28%.
NextEra Energy, Inc., through its subsidiaries, generates, transmits, distributes, and sells electric power to retail and wholesale customers in North America. The company generates electricity through wind, solar, nuclear, coal, and natural gas facilities. It also develops, constructs, and operates long-term contracted assets that consists of clean energy solutions, such as renewable generation facilities, battery storage projects, and electric transmission facilities; sells energy commodities; and owns, develops, constructs, manages and operates electric generation facilities in wholesale energy markets. As of December 31, 2021, the company had approximately 28,564 megawatts of net generating capacity; approximately 77,000 circuit miles of transmission and distribution lines; and 696 substations. It serves approximately 11 million people through approximately 5.7 million customer accounts in the east and lower west coasts of Florida. The company was formerly known as FPL Group, Inc. and changed its name to NextEra Energy, Inc. in 2010. The company was founded in 1925 and is headquartered in Juno Beach, Florida.
Earnings Per Share
As for profitability, NextEra Energy has a trailing twelve months EPS of $2.11.
PE Ratio
NextEra Energy has a trailing twelve months price to earnings ratio of 35.96. Meaning, the purchaser of the share is investing $35.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.83%.
Yearly Top and Bottom Value
NextEra Energy’s stock is valued at $75.89 at 20:15 EST, way under its 52-week high of $91.35 and way above its 52-week low of $67.22.
Volatility
NextEra Energy’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.81%, a negative 0.06%, and a positive 1.26%.
NextEra Energy’s highest amplitude of average volatility was 1.18% (last week), 1.27% (last month), and 1.26% (last quarter).
More news about NextEra Energy.
9. Royalty Pharma (RPRX) – Dividend Yield: 2.1%
Royalty Pharma’s last close was $35.38, 20.94% under its 52-week high of $44.75. Intraday change was 2.08%.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $1.93.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 18.36. Meaning, the purchaser of the share is investing $18.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.59%.
More news about Royalty Pharma.
